Literature DB >> 15635668

Serotonin transporter intron 2 polymorphism associated with rigid-compulsive behaviors in Dutch individuals with pervasive developmental disorder.

Erik J Mulder1, George M Anderson, Ido P Kema, Astrid M Brugman, Cees E J Ketelaars, Annelies de Bildt, Natasja D J van Lang, Johan A den Boer, Ruud B Minderaa.   

Abstract

Two putatively functional polymorphisms of the serotonin transporter gene (HTT, SLC6A4) were examined for associations with risk for pervasive developmental disorders (PDDs) and specific autism phenotypes. Dutch patients diagnosed with PDD (N = 125, age range 5-20 years, DSM-IV-TR based criteria, ADI-R and ADOS behavioral assessments) and their parents (N = 230) were genotyped for promoter ins/del (5-HTTLPR) and intron 2 variable number of tandem repeats (VNTR) alleles. Using the transmission disequilibrium test (TDT), no disorder-specific preferential transmission of promoter (long and short) or intron 2 (10- and 12-repeat) alleles was observed. However, multivariate analysis of continuous autism-related behavioral measures revealed that subjects with intron 2 12/12 genotype were significantly more impaired in the rigid-compulsive domain (P = 0.008). Quantitative TDT (QTDT) analysis also showed significant association of the intron 2 VNTR 12-repeat allele with rigid-compulsive behavior (P = 0.015). These results suggest that intron 2 VNTR alleles or nearby polymorphisms in linkage disequilibrium may play a role in specific aspects of the behavioral phenotype of autism. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635668     DOI: 10.1002/ajmg.b.30122

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  22 in total

1.  Macrophage migration inhibitory factor and autism spectrum disorders.

Authors:  Elena L Grigorenko; Summer S Han; Carolyn M Yrigollen; Lin Leng; Yuka Mizue; George M Anderson; Erik J Mulder; Annelies de Bildt; Ruud B Minderaa; Fred R Volkmar; Joseph T Chang; Richard Bucala
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

Review 2.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 3.  Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Authors:  Suma Jacob; Angeli Landeros-Weisenberger; James F Leckman
Journal:  Autism Res       Date:  2009-12       Impact factor: 5.216

4.  Impaired development of fetal serotonergic neurons in intrauterine growth restricted baboons.

Authors:  Wenrui Ye; Lynn Xie; Cun Li; Peter W Nathanielsz; Brent J Thompson
Journal:  J Med Primatol       Date:  2014-08       Impact factor: 0.667

5.  The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits.

Authors:  Andrea M Allan; Xiaomin Liang; Yuping Luo; Changhui Pak; Xuekun Li; Keith E Szulwach; Dahua Chen; Peng Jin; Xinyu Zhao
Journal:  Hum Mol Genet       Date:  2008-04-01       Impact factor: 6.150

6.  Genome-wide linkage analyses of two repetitive behavior phenotypes in Utah pedigrees with autism spectrum disorders.

Authors:  Dale S Cannon; Hilary Coon; Judith S Miller; Reid J Robison; Michele E Villalobos; Natalie K Wahmhoff; Kristina Allen-Brady; William M McMahon
Journal:  Mol Autism       Date:  2010-02-22       Impact factor: 7.509

7.  Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry.

Authors:  Inês Sousa; Taane G Clark; Richard Holt; Alistair T Pagnamenta; Erik J Mulder; Ruud B Minderaa; Anthony J Bailey; Agatino Battaglia; Sabine M Klauck; Fritz Poustka; Anthony P Monaco
Journal:  Mol Autism       Date:  2010-03-25       Impact factor: 7.509

Review 8.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  How to use the ADI-R for classifying autism spectrum disorders? Psychometric properties of criteria from the literature in 1,204 Dutch children.

Authors:  Annelies de Bildt; Iris J Oosterling; Natasja D J van Lang; Sanne Kuijper; Vera Dekker; Sjoerd Sytema; Anoek M Oerlemans; Daphne J van Steijn; Janne C Visser; Nanda N Rommelse; Ruud B Minderaa; Herman van Engeland; Rutger-Jan van der Gaag; Jan K Buitelaar; Maretha V de Jonge
Journal:  J Autism Dev Disord       Date:  2013-10

10.  Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse.

Authors:  Jeremy Veenstra-Vanderweele; Tammy N Jessen; Brent J Thompson; Michelle Carter; Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  J Neurodev Disord       Date:  2009-06       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.